Brief: Surmodics Q2 Loss Per Share USD 0.55
26/04/2023 12:16
Apr 26 (Reuters) - Surmodics Outlook FY revenue USD 103-106 million. * Outlook FY revenue growth 3-6% * Q2 product sales USD 15.35 million * Q2 basic EPS USD -0.55 * Q2 pretax profit USD -7.365 million * Q2 net income USD -7.733 million * Q2 EPS USD -0.55
Recent news on SurModics
See all newsU.S. STOCKS ON THE MOVE-Surmodics, Cheniere Energy, American Public Education
U.S. STOCKS ON THE MOVE-Surmodics, Energy stocks, American Public Education
Surmodics jumps after US judge rejects FTC's bid to block acquisition by GTCR
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions